First-in-Human Safety, Pharmacokinetics and Pharmacodynamics of THB001: An Orally Available, Potent and Highly Selective Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase

H._withStripped=!0;var w=n(135),D=n.n(w),g=n(303),M={data:function(){return{scrolled:null,animationPlayed:!1,tl:h.a.timeline({paused:!0,delay:1})}},components:{LottieWeb:D.a},watch:{"$root.introLogoMoving":function(){this.animationPlayed||this.tl.play()}},methods:{animation:function(){var t=this.$refs.harmonic;this.tl.to(t,1,{autoAlpha:1},1)},percentScrolled:function(){var t=document.documentElement,e=document.body,n="scrollTop",r="scrollHeight",s=Math.floor((t[n]||e[n])/((t[r]||e[r])-t.clientHeight)*100);this.scrolled=s||0}},mounted:function(){this.animation(),document.addEventListener("scroll",this.percentScrolled);var t=this.$refs.animationContainer;D.a.loadAnimation({container:t,renderer:"svg",autoplay:!0,loop:!0,animationData:g})